The IBD Therapeutics Incubator from the Crohn’s & Colitis Foundation provides funding and innovation support for researchers working on new therapeutics for inflammatory bowel disease (IBD). This will be a partnership between the Foundation, academic researchers and a specialized contract research organization (CRO). Applications are open to senior researchers worldwide, and applicants from underrepresented populations in biomedical research are highly encouraged to apply. The Foundation expects to invest up to 1.5 million USD over 3 years. Applicant's institutions must request for the collaboration agreement by August 30, 2022. Full applications are due on October 3, 2022.
October 3, 2022